Evidence map›Paper›PMID 39961959›Full record

ReviewClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2025

Clinical advances and practice updates in genitourinary cancers: a 2024 review from the multidisciplinary Spanish 'Cambados annual meeting'.

Ignacio Peláez, Martín Lázaro-Quintela, Daniel Pérez-Fentes, Emilio Esteban-González, Enrique Gallardo, Carlos Álvarez-Fernández, Pablo Álvarez Rodríguez, Urbano Anido-Herranz, Cristina Azpitarte Raposeiras, Ángel Maximino Castro-Iglesias and 9 more

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Clinical advances and practice updates in genitourinary cancers: a 2025 review from the multidisciplinary Spanish 'Cambados annual meeting'.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Ignacio PeláezMedical Oncology Service, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain.
Martín Lázaro-QuintelaMedical Oncology Department, Complexo Hospitalario Universitario de Vigo, Pontevedra, Spain.
Daniel Pérez-FentesUrology Department, Complexo Hospitalario Universitario de Santiago de Compostela, A Coruña, Spain.
Emilio Esteban-GonzálezMedical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Enrique GallardoDepartment of Oncology, Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain.
Carlos Álvarez-FernándezMedical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Pablo Álvarez RodríguezMedical Oncology Department, Centro Oncológico de Galicia, A Coruña, Spain.
Urbano Anido-HerranzMedical Oncology Department, Complexo Hospitalario Universitario de Santiago de Compostela, A Coruña, Spain.
Cristina Azpitarte RaposeirasMedical Oncology Department, Hospital Universitario de Pontevedra, Pontevedra, Spain.
Ángel Maximino Castro-IglesiasUrology Department, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
Ovidio Fernández CalvoMedical Oncology Department, Complejo Hospitalario Universitario Ourense, Ourense, Spain.
Natalia Fernández NúñezMedical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain.
Alicia Folgar-TorresRadiation Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain.
Carme García LorenzoMedical Oncology Department, Complexo Hospitalario Universitario Ferrol, A Coruña, Spain.
Aránzazu González-Del-AlbaMedical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
María José Méndez-VidalMedical Oncology Department, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Córdoba, Spain.
Aurea Molina DíazMedical Oncology Department, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Ignacio Rodríguez GómezUrology Department, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Sergio Vázquez-EstévezMedical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain. Sergio.Vazquez.Estevez@sergas.es.ORCID http://orcid.org/0000-0002-4973-3198

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate, bladder and kidney neoplasms are among the most prevalent genitourinary (GU) cancers worldwide. Significant therapeutic advancements in recent years have substantially improved patient outcomes. In response to this rapid progress, the Santiago de Compostela Health Research Institute (IDIS) has organized the annual 'Cambados Consensus Forum on Genitourinary Tumors' (Pontevedra, Spain) since 2018. This 2-day multidisciplinary meeting gathers Spanish medical oncologists, radiation oncologists, urologists, and hospital pharmacists to present and discuss the latest evidence in the field, merging from international congresses or journal publications. This review provides an overview of the most recent evidence regarding therapeutic advances in prostate cancer, renal cell carcinoma, and bladder cancer presented at the 2024 meeting (October), with a special focus on practice-changing innovations.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsProstatic NeoplasmsUrinary Bladder NeoplasmsUrogenital NeoplasmsCongresses as TopicHumansMaleSpainBladder cancerKidney neoplasms (MeSH)Practice-changingProstate cancerProstatic neoplasms (MeSH)Renal cancerRenal cell carcinomaUrinary bladder neoplasms (MeSH)

Identifiers

PMID39961959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.